Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

por Hussen, Bashdar Mahmud, Rasul, Mohammed Fatih, Abdullah, Snur Rasool, Hidayat, Hazha Jamal, Faraj, Goran Sedeeq Hama, Ali, Fattma Abodi, Salihi, Abbas, Baniahmad, Aria, Ghafouri-Fard, Soudeh, Rahman, Milladur, Glassy, Mark C., Branicki, Wojciech, Taheri, Mohammad
Publicado 2023